Swedish test may boost pancreatic cancer survival rates

March 18, 2014

Swedish researchers have developed a new method for diagnosing pancreatic cancer at a much earlier stage than currently possible, the University of Gothenburg said Tuesday.

The test detects the first signs of the with 97 percent accuracy, which researchers hope will help improve the low survival rate among those diagnosed.

Only five percent of patients with pancreatic cancer survive more than five years after their diagnosis as tumours often develop unnoticed and spread to other organs before being detected.

"We are very hopeful that the method will enable more instances of early discovery of at a stage when the cancer can be treated or prevented," Karolina Jabbar, part of the research team at the Sahlgrenska Academy, said in a statement.

"Thanks to this analysis, we can see at what stage the is," she told AFP.

The test works like a normal endoscopy, where a tube is placed inside a patient's mouth and then fed down into the stomach.

"The difference is that the tube takes ultra sound (images) so you can see the organ much better and then you can take off fluids," said Jabbar.

The procedure is not only expected to help detect cancers early but also reduce the risk of unnecessary surgery.

Existing tumours can be tested with the method, with an of about 90 percent, making it easier to determine if a patient needs immediate surgery.

Explore further: Screen some patients with acute pancreatitis for pancreatic cancer, researchers suggest

Related Stories

Screen some patients with acute pancreatitis for pancreatic cancer, researchers suggest

February 26, 2014
In a study published in Clinical Gastroenterology and Hepatology, Saint Louis University researchers have found a link between acute pancreatitis (inflammation of the pancreas) and pancreatic cancer, a finding which may eventually ...

Game changer: Biomarker identified for noncancerous pancreatic cysts

February 11, 2014
Researchers at the Indiana University School of Medicine have discovered a highly accurate, noninvasive test to identify benign pancreatic cysts, which could spare patients years of nerve-racking trips to the doctor or potentially ...

Pancreatic cancer surgery findings presented at SSO

March 13, 2014
Despite the benefits of surgery for early stage pancreatic cancer, it remains under-utilized for patients with this deadly disease, according to a new national analysis of trends and outcomes. Physician-scientists at University ...

New findings show link between diabetes and pancreatic cancer

March 14, 2014
In a new study published today in Annals of Surgical Oncology, clinicians worked with mathematicians to review data from 1973 to 2013 to conclude there was a time-dependent link between being diagnosed with diabetes and pancreatic ...

A simple test may catch early pancreatic cancer

October 23, 2013
Reporting on a small preliminary study, Johns Hopkins researchers say a simple blood test based on detection of tiny epigenetic alterations may reveal the earliest signs of pancreatic cancer, a disease that is nearly always ...

Key find for early bladder cancer treatment

May 23, 2013
Aggressive forms of bladder cancer involve the protein PODXL – a discovery that could hold the key to improved treatment, according to researchers at Lund University, Uppsala University and KTH in Sweden.

Recommended for you

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Combining CAR T cells with existing immunotherapies may overcome resistance in glioblastomas

July 19, 2017
Genetically modified "hunter" T cells successfully migrated to and penetrated a deadly type of brain tumor known as glioblastoma (GBM) in a clinical trial of the new therapy, but the cells triggered an immunosuppressive tumor ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.